Old Web
English
Sign In
Acemap
>
authorDetail
>
Renée Miceli
Renée Miceli
Mapatumumab
Medicine
Immunology
Pharmacokinetics
Tolerability
3
Papers
327
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma
2010
British Journal of Cancer
Anas Younes
Julie M. Vose
Andrew D. Zelenetz
Mitchell R. Smith
Howard A. Burris
Stephen Maxted Ansell
Jerry L. Klein
W. Halpern
Renée Miceli
Elizabeth Kumm
N. L. Fox
Myron S. Czuczman
Show All
Source
Cite
Save
Citations (113)
Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study
2009
Clinical Cancer Research
C. H. Mom
Jaap Verweij
Corina N.A.M. Oldenhuis
Jourik A. Gietema
N. L. Fox
Renée Miceli
Ferry A.L.M. Eskens
Walter J. Loos
Elisabeth G.E. de Vries
Stefan Sleijfer
Show All
Source
Cite
Save
Citations (92)
Mapatumumab, an Antibody Targeting TRAIL-R1, in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Malignancies: Results of a Phase I and Pharmacokinetic Study
2009
Journal of Clinical Oncology
Stephen Leong
Roger B. Cohen
Daniel L. Gustafson
Corey J. Langer
D. Ross Camidge
Kristin Padavic
Lia Gore
Margaret Smith
Laura Q. Chow
Margaret von Mehren
Cindy L. O'Bryant
Sujatha Hariharan
Sami G. Diab
N. L. Fox
Renée Miceli
S. Gail Eckhardt
Show All
Source
Cite
Save
Citations (122)
1